Arcadia Biosciences (RKDA) Total Liabilities (2014 - 2025)

Arcadia Biosciences has reported Total Liabilities for 12 years, with the latest figure at $2.4 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities fell 67.01% year-over-year to $2.4 million; the trailing twelve-month figure through Dec 2025 stood at $2.4 million (down 67.01% YoY), and the FY2025 full-year result was $2.4 million, down 67.01% from the prior year.
• Total Liabilities for Q4 2025 stood at $2.4 million, down from $3.1 million in the prior quarter.
• The five-year high for Total Liabilities was $28.1 million in Q2 2021, with the low at $2.4 million in Q4 2025.
• Historically, Total Liabilities has averaged $9.7 million across 5 years, with a median of $8.0 million in 2022.
• Annual changes were most pronounced in 2022 — Total Liabilities slumped 70.7% — and 2023, when it soared 60.31%.
• Arcadia Biosciences' Total Liabilities stood at $12.7 million in 2021, then plunged by 36.94% to $8.0 million in 2022, then decreased by 12.72% to $7.0 million in 2023, then gained by 4.17% to $7.3 million in 2024, then plunged by 67.01% to $2.4 million in 2025.
• The last three Total Liabilities figures came in at $2.4 million (Q4 2025), $3.1 million (Q3 2025), and $3.3 million (Q2 2025), per Business Quant data.